en
Feedback
Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Open in Telegram

Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

Show more

📈 Analytical overview of Telegram channel Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

Channel Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ (@smartlearningacademy) in the English language segment is an active participant. Currently, the community unites 18 651 subscribers, ranking 10 717 in the Education category and 22 673 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 18 651 subscribers.

According to the latest data from 10 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 221 over the last 30 days and by 8 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 13.95%. Within the first 24 hours after publication, content typically collects 6.65% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 2 601 views. Within the first day, a publication typically gains 1 241 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 4.
  • Thematic interests: Content is focused on key topics such as vedemy, nat, revision, calculation, rahe.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

Thanks to the high frequency of updates (latest data received on 11 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Education category.

18 651
Subscribers
+824 hours
+397 days
+22130 days
Posts Archive
🌟 Exciting News for the Future of Medicine! 🌟 Hey Students! 🚀 Guess what? 🎉 The U.S. FDA just gave the green light to two AMAZING gene therapies, Casgevy and Lyfgenia, for treating sickle cell disease in patients aged 12 and older! 🩸💪 Casgevy is making history as the FIRST-EVER FDA-approved therapy to use CRISPR/Cas9! 🧬 This cutting-edge tech edits blood stem cells, preventing red blood cell sickling and boosting oxygen delivery. 🌬 Lyfgenia, another game-changer, uses a lentiviral vector for genetic modification, introducing HbAT87Q to mimic normal hemoglobin and reduce sickling risks! 🧬🚑 Both therapies use the patient's OWN stem cells for a one-time, single-dose infusion - talk about personalized medicine! 🩹💉 As future scientists, this is YOUR world of possibilities! 🌍✨ Stay curious, work hard, and dream BIG! 🚀 Your careers could be at the forefront of these groundbreaking innovations. 🌈 The FDA's approval of Casgevy and Lyfgenia is a high-five to the importance of scientific exploration. 🖐💡 So, keep dreaming, keep learning, and get ready to change the world! 🌟🔬 Cheers to the future of medicine and YOUR incredible journey ahead! 🎓👩‍🔬👨‍⚕️ Keep shining bright, 🌟

All PDFs of biodiversity will be available on the app by this evening

🌱✨ Quiz Alert: Unit Wise Edition ! ✨🌱 Get ready for an exciting Unit Wise quiz series , starting this Tuesday to Friday at 10 PM! 🕙🔬 📅 Tuesday: Unit 1 📅 Wednesday: Unit 2 📅 Thursday: Unit 3 📅 Friday: Unit 4

Plant hormones quiz starting in a minute

From Monday onwards, unit wise quizzes will be conducted

Plant Hormone quiz will be conducted tomorrow @10 PM

Some genuine feedbacks
Some genuine feedbacks